[DPHARMA] YoY Quarter Result on 30-Jun-2012 [#2]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
16-Aug-2012
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2012
Quarter
30-Jun-2012 [#2]
Profit Trend
QoQ- 2.37%
YoY- -0.94%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Quarter Result
30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 CAGR
Revenue 56,308 40,623 37,988 34,355 35,345 35,982 34,062 8.73%
PBT 8,407 10,107 13,007 9,037 9,292 9,790 10,968 -4.33%
Tax -2,559 -2,594 -2,318 -2,170 -2,360 -2,484 -2,485 0.49%
NP 5,848 7,513 10,689 6,867 6,932 7,306 8,483 -6.00%
-
NP to SH 5,848 7,513 10,689 6,867 6,932 7,306 8,483 -6.00%
-
Tax Rate 30.44% 25.67% 17.82% 24.01% 25.40% 25.37% 22.66% -
Total Cost 50,460 33,110 27,299 27,488 28,413 28,676 25,579 11.98%
-
Net Worth 189,815 179,145 187,404 162,310 154,198 140,286 136,061 5.70%
Dividend
30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 CAGR
Div 5,582 5,554 5,552 4,855 4,862 6,250 83 101.59%
Div Payout % 95.47% 73.94% 51.95% 70.71% 70.14% 85.55% 0.98% -
Equity
30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 CAGR
Net Worth 189,815 179,145 187,404 162,310 154,198 140,286 136,061 5.70%
NOSH 139,570 138,872 138,818 138,727 138,917 138,897 138,837 0.08%
Ratio Analysis
30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 CAGR
NP Margin 10.39% 18.49% 28.14% 19.99% 19.61% 20.30% 24.90% -
ROE 3.08% 4.19% 5.70% 4.23% 4.50% 5.21% 6.23% -
Per Share
30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 CAGR
RPS 40.34 29.25 27.37 24.76 25.44 25.91 24.53 8.64%
EPS 4.19 5.41 7.70 4.95 4.99 5.26 6.11 -6.09%
DPS 4.00 4.00 4.00 3.50 3.50 4.50 0.06 101.30%
NAPS 1.36 1.29 1.35 1.17 1.11 1.01 0.98 5.61%
Adjusted Per Share Value based on latest NOSH - 138,727
30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 CAGR
RPS 5.85 4.22 3.95 3.57 3.67 3.74 3.54 8.72%
EPS 0.61 0.78 1.11 0.71 0.72 0.76 0.88 -5.92%
DPS 0.58 0.58 0.58 0.50 0.51 0.65 0.01 96.68%
NAPS 0.1973 0.1862 0.1948 0.1687 0.1603 0.1458 0.1414 5.70%
Price Multiplier on Financial Quarter End Date
30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 CAGR
Date 30/06/15 30/06/14 28/06/13 29/06/12 30/06/11 30/06/10 30/06/09 -
Price 2.65 2.97 2.38 2.23 2.34 2.45 2.13 -
P/RPS 6.57 10.15 8.70 9.00 9.20 9.46 8.68 -4.53%
P/EPS 63.25 54.90 30.91 45.05 46.89 46.58 34.86 10.43%
EY 1.58 1.82 3.24 2.22 2.13 2.15 2.87 -9.46%
DY 1.51 1.35 1.68 1.57 1.50 1.84 0.03 92.09%
P/NAPS 1.95 2.30 1.76 1.91 2.11 2.43 2.17 -1.76%
Price Multiplier on Announcement Date
30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 CAGR
Date 25/08/15 26/08/14 28/08/13 16/08/12 18/08/11 24/08/10 26/08/09 -
Price 2.40 3.37 2.44 2.38 2.22 2.45 2.50 -
P/RPS 5.95 11.52 8.92 9.61 8.73 9.46 10.19 -8.57%
P/EPS 57.28 62.29 31.69 48.08 44.49 46.58 40.92 5.76%
EY 1.75 1.61 3.16 2.08 2.25 2.15 2.44 -5.38%
DY 1.67 1.19 1.64 1.47 1.58 1.84 0.02 108.99%
P/NAPS 1.76 2.61 1.81 2.03 2.00 2.43 2.55 -5.98%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment